[Changes in prostatic stromal composition and benign prostatic hyperplasia]. 2011

Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
Department of Urology, Guangzhou General Hospital of Guangzhou Military Region, Guangzhou, Guangdong 510010, China.

OBJECTIVE To investigate whether there are different stromal compositions in the prostate tissue of patients with benign prostatic hyperplasia (BPH) and evaluate their significance in the course of the disease. METHODS Forty-three surgical or bioptic prostatic specimens of BPH and 5 autoptic normal prostatic specimens were stained by the Masson method to display the elements of the muscle fiber and collagen. The relationship of the changes in the prostatic stromal composition was analyzed with the degree of bladder outlet obstruction (BOO) , IPSS and medication results. RESULTS The mean ratio of muscle fiber to collagen in the normal prostate tissue was (3.2 +/- 0.2):1, significantly higher than that of the BPH patients (1: [4.7 +/- 3.1] ) (P < 0.01); that in the BPH patients with BOO was 1: (5.4 +/- 3.7) markedly lower than in those without BOO (1: [2.5 +/- 1.1] ) (P = 0.02); that in the BPH patients with severe prostatic symptoms was 1: (9.1 +/- 2.9), remarkably lower than in those with moderate (1: [5.3 +/- 3.4]) and mild prostatic symptoms (1: [2.8 +/- 1.7]) (P < 0.01); and that in the BPH patients with satisfactory medicinal therapeutic results was 1:(2.3 +/- 1.9), significantly higher than in those with poor therapeutic results (1: [7.6 +/- 4.3]) (P < 0.01). CONCLUSIONS The stromal composition in the prostatic tissue of BPH patients undergoes different degrees of changes. More obvious BPH symptoms and poorer therapeutic results are associated with a bigger proportion of collagens and a smaller proportion of muscle fibers in the prostatic tissue. These changes may play an important role in the development and progression of BPH.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D001748 Urinary Bladder Neck Obstruction Blocked urine flow through the bladder neck, the narrow internal urethral opening at the base of the URINARY BLADDER. Narrowing or strictures of the URETHRA can be congenital or acquired. It is often observed in males with enlarged PROSTATE glands. Bladder Neck Obstruction,Bladder Outlet Obstruction
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
January 1996, European urology,
Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
November 1989, Der Urologe. Ausg. A,
Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
November 2003, The Journal of urology,
Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
January 1996, European urology,
Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
May 2010, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
October 2014, The Prostate,
Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
February 2009, The Journal of urology,
Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
July 2023, International journal of molecular sciences,
Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
December 2001, The Prostate,
Wen Shen, and Xiang-Ming Mao, and Jun Lü, and Hua-Qiang Yao, and Zhi-Xiong Deng, and Yong-Bin Zhao, and Jun Liu, and Wei Hua, and Bang-Qi Wang, and Wei-Lie Hu
December 2009, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Copied contents to your clipboard!